Clinical Trial Update: The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating botulinum toxin for disabling tremor in multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Melbourne Health | Conditions: Multiple Sclerosis, Tremor | Phase 3 | Status: COMPLETED